EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19

Rodolfo Pedro Rothlin iD, Facundo Germán Pelorosso, Mariano Duarte, Liliana Nicolosi, Fernandez Criado Ignacio, María Victoria Salgado, Héctor Vetulli

Pharmacology Research & Perspectives · 2023

DOI: 10.1002/prp2.1083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2023. Verfasst von Rodolfo Pedro Rothlin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sociedad Argentina de Farmacología Clínica, Asociación Médica Argentina, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: COVID-19, Hypertension. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HypertensionHumansLosartanTelmisartanAntihypertensive Agents

Substanzen

LosartanTelmisartanAntihypertensive Agents

Autor:innen und Institutionen

  • Sociedad Argentina de Farmacología Clínica, Asociación Médica Argentina, Buenos Aires, Argentina.
  • Servicio de Anatomía Patológica, Hospital de Alta Complejidad El Calafate SAMIC, Santa Cruz, Argentina.
  • Laboratorio de Hipertensión, División de Cardiología, Hospital de Clínicas "José de San Martín", Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Segunda Cátedra de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • División de Cardiología, Hospital Español de Buenos Aires, Buenos Aires, Argentina.
  • Sección de Tecnología Educativa e Informática Médica, Hospital de Clínicas "José de San Martín", Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

ORCID-Profile: Rodolfo Pedro Rothlin

Zitieren

APA

Rothlin, R. P., Pelorosso, F. G., Duarte, M., Nicolosi, L., Ignacio, F. C., Salgado, M. V., & Vetulli, H. (2023). Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1083

Vancouver

Rothlin RP, Pelorosso FG, Duarte M, Nicolosi L, Ignacio FC, Salgado MV, et al. Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19. Pharmacology Research & Perspectives. 2023. doi:10.1002/prp2.1083

BibTeX
@article{Rothlin2023,
  author = {Rothlin, Rodolfo Pedro and Pelorosso, Facundo Germán and Duarte, Mariano and Nicolosi, Liliana and Ignacio, Fernandez Criado and Salgado, María Victoria and Vetulli, Héctor},
  title = {Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19},
  journal = {Pharmacology Research & Perspectives},
  year = {2023},
  doi = {10.1002/prp2.1083}
}
Kostenlos starten →